BIOLASE, Inc. - BIOL

SEC Filings Our BIOL Tweets

About Gravity Analytica

Recent News

  • 07.22.2026 - BIOLASE and MegaGen America Launch U.S. Commercial Collaboration to Advance “More Brilliant Dentistry Together”
  • 06.25.2026 - MegaGen and BIOLASE Invest Nearly $1 Million to Expand Manufacturing Infrastructure at Corona, California Facility
  • 02.19.2026 - Dr. Wynn Okuda on Elevating Cosmetic and Implant Dentistry with the BIOLASE Waterlase iPlus
  • 06.27.2025 - What Type of Dental Laser Is Best for My Practice?
  • 06.20.2025 - MegaGen x BIOLASE, Integrating Innovation for a Future Beyond
  • 07.11.2024 - Waterlase iPlus Premier: Celebrating a Spot in Dentistry Today’s Top 100 Products of 2024
  • 07.11.2024 - Waterlase iPlus Premier: Celebrating a Spot in Dentistry Today’s Top 100 Products of 2024
  • 05.13.2024 - Biolase Reports 2024 First Quarter Results; Reiterates Full-Year 2024 Guidance For Revenue Growth and Profitability
  • 05.06.2024 - BIOLASE to Report First Quarter 2024 Results on May 13, 2024
  • 03.21.2024 - Biolase Reports Full-Year 2023 Results; Expects Continued Revenue Growth In 2024

Recent Filings

  • 04.21.2025 - SEC STAFF ACTION SEC Staff Action: ORDER
  • 11.14.2024 - SC 13G/A Statement of Beneficial Ownership by Certain Investors
  • 11.14.2024 - SC 13G/A Statement of Beneficial Ownership by Certain Investors
  • 11.07.2024 - 10-Q Quarterly report [Sections 13 or 15(d)]
  • 10.08.2024 - 8-K Current report
  • 10.01.2024 - EX-99.1 EX-99.1
  • 10.01.2024 - 8-K Current report
  • 09.06.2024 - 8-K Current report
  • 09.06.2024 - 25-NSE Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
  • 08.28.2024 - 8-K Current report